Stay updated on NSCLC Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the NSCLC Immunotherapy Clinical Trial page.

Latest updates to the NSCLC Immunotherapy Clinical Trial page
- Check4 days agoChange DetectedThe Taiwan location label in the locations list was updated from Taoyuan, Taiwan, 333 to Taoyuan City, Taiwan, 333. The update keeps the same address but uses the official city designation for that site.SummaryDifference0.0%

- Check11 days agoChange DetectedThe revision label on the page has been updated from v3.5.2 to v3.5.3, indicating a new page revision is now in effect. This appears to be a metadata or versioning update rather than a substantive change to the study details.SummaryDifference0.0%

- Check18 days agoChange DetectedUpdated the Chile location text by removing the “Región de Valparaíso” wording while keeping the same city/address line. Also reflects minor text formatting changes for the sponsor name and a software revision/version string.SummaryDifference0.2%

- Check47 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131. Page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page now includes updated results data with progression-free survival and overall survival outcomes, along with updated study dates. This adds core trial findings to the page.SummaryDifference0.0%

Stay in the know with updates to NSCLC Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Immunotherapy Clinical Trial page.